Evidence map›Paper›PMID 42773377›Full record

ArticleCell biology and toxicology2026

Correction to: Chronic cadmium exposure promotes TRPM7‑dependent acquisition of a myofibroblast‑like phenotype in pancreatic stellate cells.

Mathilde Fourgeaud, Julie Auwercx, Alexis Lalot, Laure Noé, Belinda Duchêne, Anthony Verdin, Sara Agrane, Frédéric Hague, Stéphanie Guénin, Nour Jaber and 9 more

Abstract readPublished Erratum
In one paragraph

Article in Cell biology and toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Mathilde FourgeaudUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Julie AuwercxUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Alexis LalotUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Laure NoéUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Belinda DuchêneUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Anthony VerdinUniversite du Littoral Cote d'Opale, UCEIV UR4492, 59375, Dunkerque, France.
Sara AgraneUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Frédéric HagueUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Stéphanie GuéninCentre de Ressources Regionales en Biologie Moleculaire (CRRBM), Universite de Picardie Jules Verne, 80039, Amiens, France.
Nour JaberUniversite du Littoral Cote d'Opale, UCEIV UR4492, 59375, Dunkerque, France.
Aurélie Dupont-DeshorgueUniversite de Reims Champagne-Ardenne, UMR7369 CNRS, MEDYC, F‑51095, Reims, France.
Laurent GutierrezCentre de Ressources Regionales en Biologie Moleculaire (CRRBM), Universite de Picardie Jules Verne, 80039, Amiens, France.
Denis ChatelainUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Frédéric LedouxUniversite du Littoral Cote d'Opale, UCEIV UR4492, 59375, Dunkerque, France.
Isabelle Dhennin-DuthilleUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Bertrand BrassartUniversite de Reims Champagne-Ardenne, UMR7369 CNRS, MEDYC, F‑51095, Reims, France.
Sylvie Brassart-PascoUniversite de Reims Champagne-Ardenne, UMR7369 CNRS, MEDYC, F‑51095, Reims, France.
Nicolas JonckheereUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France.
Mathieu GautierUniversité de Picardie Jules Verne, Univ. Lille, Inserm, CHU de Lille, CNRS, U1366-UMR9020, CRCLille - Cancer Research Center of Lille, 80039, Amiens, France. mathieu.gautier@u-picardie.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42773377
PMCPMC13597615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.